Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Hoping to catch serious illnesses early, more Americans are ordering lab tests online, but their doctors don't know what to ...

First discovered in the 1950s, NGF is now known to direct the growth, maintenance, proliferation and preservation of neurons ...

Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...

A total of 395 students at Mitchell Technical College have been placed on the Fall Semester 2025 President’s List, according ...

Ulta Lab Tests, LLC, is not a clinical laboratory certified under federal law and, as such, does not meet HAR requirements to ...

The Department of Health ordered Ulta Lab Tests LLC to end its affiliations with three entities acting as collecting depots.

CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034Precision Pathology Laboratory Services meets gold standard for excellence across all ...

According to the directive, sample collection is only allowed at the trade license address, and auto-generated reports must be verified and signed by a specialist physician.

bioAffinity Technologies, Inc. (NASDAQ:BIAF) announced on Monday that Dr. Roby P. Joyce has transferred 100% of his ownership interest in Village Oaks Pathology Services, P.A. to Dr. James Humphreys.

This article first appeared on GuruFocus. Rocket Lab Corporation (NASDAQ:RKLB) jumped about 8% on Monday after investors cheered on capping a record year with its 21st Electron rocket launch, sending ...

Artificial intelligence (AI) chatbots may be able to help interpret pathology reports for patients, but at this point they need clinician review before being delivered, researchers said. Among 1,134 ...